Jefferies analyst Anthony Petrone came out to defend Haemonetics (NYSE: HAE) calling the sell-off overdone and providing a good entry ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments

Haemonetics (HAE) Tops Q3 EPS by 4c, Revenues Miss; Offers FY19 EPS Mid-Point Guidance Below ConsensusFebruary 5, 2019 6:11 AM Form 8-K HAEMONETICS CORP For: Feb 05February 5, 2019 6:09 AM Haemonetics 3rd Quarter Fiscal 2019 Earnings Release Available on Investor Relations WebsiteFebruary 5, 2019 6:00 AM